+1-855-874-6736 | CIG@trinseo.com
United States & Canada | Global Directory »

Editorial Information

Trinseo Continues its Focus on Drug Delivery Devices with Rigid and Soft Plastics

Company will Showcase Resins at Medtec Europe in Stuttgart, April 17 - 19

BERWYN, Pa. - Tuesday, April 17, 2018

Last year, Trinseo (NYSE: TSE), a global materials solutions provider and manufacturer of plastics, latex binders and synthetic rubber, began supporting the Drug Delivery Devices market with its specialty engineered resins. The company has highlighted its materials at trade shows worldwide including MD&M West in California, Pharmapack in Paris, and the International Component Manufacturing and Design Show in Shanghai.

Trinseo will be showcasing its plastic resins at Medtec Europe in Stuttgart from April 17 to 19, co-located with one of its European distributor partners VELOX in Hall 9, Booth 9E38. 

Typical drug delivery devices, also known as pre-filled or combination devices that can use Trinseo materials include auto injectors, insulin pens, asthma inhalers, prefilled syringes and wearable devices. The company’s specialty compounded solutions are ideal for a wide range of applications – MAGNUM™ ABS, CALIBRE™ Polycarbonate, STYRON Polystyrene, and EMERGE™ Advanced Resins for rigid plastic applications, and RAPLAN™ and MEGOL™ Thermoplastic Elastomers for soft touch and over molding needs.

Trinseo is ISO 13485 certified and a trusted partner of global product designers, manufacturers and molders of medical devices. Large and global in its infrastructure yet agile in its service model, the company is known for its quality, technical knowledge, and regulatory support services, which enable customers to lower risk and take products to market sooner.  

As the healthcare industry continues to look for ways to enhance patient care, improve quality of life, and reduce costs, self-administered therapies are providing a viable solution. Health care providers need devices that are effective therapeutically and also are convenient, functional and aesthetically pleasing.  Plastic resin materials are a big part of the solution. Trinseo, with nearly three decades of experience with medical polymers, is supporting global customers with this challenge.

Contact Wassim Berrak to arrange a time to meet at the show or connect with Trinseo at www.trinseo.com.

About Trinseo

Trinseo (NYSE: TSE) is a global materials solutions provider and manufacturer of plastics, latex binders, and synthetic rubber. We are focused on delivering innovative and sustainable solutions to help our customers create products that touch lives every day — products that are intrinsic to how we live our lives — across a wide range of end-markets, including automotive, appliances, consumer electronics, medical devices, electrical, building and construction, textile, paper and board, footwear and tires. Trinseo had approximately $4.4 billion in net sales in 2017, with 16 manufacturing sites around the world, and approximately 2,200 employees. For more information visit www.trinseo.com

Note on Forward-Looking Statements

This press release may contain “forward-looking statements” within the meaning of the safe harbor provisions of the United States Private Securities Litigation Reform Act of 1995. Words such as “expect,” “estimate,” “project,” “budget,” “forecast,” “anticipate,” “intend,” “plan,” “may,” “will,” “could,” “should,” “believes,” “predicts,” “potential,” “continue,” and similar expressions are intended to identify such forward-looking statements. Forward-looking statements in this press release may include, without limitation, forecasts of growth, revenues, business activity, acquisitions, financings and other matters that involve known and unknown risks, uncertainties and other factors that may cause results, levels of activity, performance or achievements to differ materially from results expressed or implied by this press release. As a result of the foregoing considerations, you are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date of this press release. The Company undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.

Editorial Information